San Francisco's First MGM-15 Death Puts a Gas-Station Opioid on the Record
The product was sold as a plant supplement. The opioid inside it is Schedule I.
The purple package in the health department’s photo says “paradise blend” and lists cat’s claw extract. It does not say kratom. It does not say MGM-15. That gap is how a gas-station shelf can hold an opioid, and the context in which, in the September data, San Francisco recorded its first fatal overdose tied to MGM-15.
A product can be legal to stock and lethal to take, and the label is where the law and the body stop agreeing.
Here is what is known. MGM-15 is a kratom-derived synthetic opioid, according to KQED’s Kevin Stark, which reported the city’s medical examiner counted 48 accidental overdose deaths in September and 399 for the year. A federal filing cited in the story says MGM-15 has stronger effects than morphine, and the DEA has put it in Schedule I. Utah and Washington officials had already tied deaths to it, Hoodline reported. San Francisco’s behavioral health director, Hillary Kunins, told reporters at a Friday press conference that “the products are not safe and can pose a risk of overdosing,” and advised people to skip products from unreliable sources. The health department’s photo is of a supplement-style package; the story does not establish that this specific product is the one linked to the death, and I’m not going to pretend it does. Nearly half of the September deaths were in ZIP codes covering the Tenderloin, Civic Center, and Mid-Market, and most decedents were white men.
Here is the part that matters for anyone near a counter, a clinic, or a person who uses. Kratom products have been sold for years as a plant, which is why some people reach for them without a prescription. A synthetic opioid derived from kratom and sold in the same aisle is a different animal, and the customer cannot tell by looking. Officials say anyone believed to be overdosing on MGM-15 should be given naloxone. The same advice applies to every opioid overdose, which means the clinical move this week is boring and correct: carry it, say so out loud to clients who buy “natural” products, and ask what the label says when someone describes withdrawal-like symptoms from a gas-station product.
If you use kratom-labeled products to get through withdrawal or pain, you are owed a real answer, not a lecture. Naloxone is on pharmacy shelves without a prescription, and a treatment program can talk to you about medicine that does the same job with a known dose.
The label said cat’s claw. The person who bought it deserved to know what they were holding.
Sources Cited
- 01.B
- 02.C
Filed Under
trendsharm-reductionbiologyKratomNaloxoneOverdose
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
The House Voted to Schedule Xylazine. The Drug That Replaced It Sends People to the ICU.
Nine states scheduled xylazine and saw medetomidine reports climb. As Congress weighs a federal xylazine ban, hospitals report ICU-level withdrawal and people who use say the sedation can't be fought. What helps now.
Harm ReductionIf Someone Stays Under After Naloxone, the Supply Changed. Medetomidine Is Why.
Medetomidine has replaced xylazine in the fentanyl supply, according to 2026 lab data. Naloxone does not reverse it, and its withdrawal can look like a cardiac emergency.
Harm ReductionA Blister Pack That Looks Like Xanax Is Now Linked to Several Overdoses in Dublin
A new, unnamed benzodiazepine stronger than Valium or Xanax is linked to overdoses in Dublin, sold in blister packs that look legitimate. What it means for anyone who relies on a pill's packaging.